Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
The Shift Toward Affordable Metabolic Health: The ‘Generic Effect’ The arrival of generic semaglutide in the Canadian market marks a pivotal turning point in how we approach metabolic health. For years, GLP-1 receptor agonists like Ozempic have been viewed as “miracle drugs,” but their high cost and limited availability created a barrier between the treatment … Read more